Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
Foghorn Therapeutics Inc. (FHTX)
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jefferies Global Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases. Jefferies Global Healthcare Conference Presentation: Wednesday, June 5, 2024, at 3:30 p.m. ET at the Marriott Marquis New York, New YorkFoghorn Presenter: Adrian Gottschalk, President and Chief Executive OfficerPlease find a link to the webcast hereManagement will also participate in one-on-one meetings on Wednesday, June 5 Goldman Sachs 45th Annual Global Healthcare Conference Presentation:
Show less
Read more
Impact Snapshot
Event Time:
FHTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FHTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FHTX alerts
High impacting Foghorn Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
FHTX
News
- Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline [Yahoo! Finance]Yahoo! Finance
- Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance PipelineGlobeNewswire
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]Yahoo! Finance
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
FHTX
Earnings
- 8/4/23 - Beat
FHTX
Sec Filings
- 6/24/24 - Form 4
- 6/10/24 - Form SC
- 6/3/24 - Form 8-K
- FHTX's page on the SEC website